[
Bansil, R., Turner, B. S. (2018). The biology of mucus: Composition, synthesis and organization. Adv. Drug Deliv. Rev., 124, 3–15.10.1016/j.addr.2017.09.02328970050
]Search in Google Scholar
[
Berg, G., Rybakova, D., Fischer, D., Cernava, T., Vergès, M. C. C., Charles, T., Chen, X., Cocolin, L., Eversole, K., et al. (2020). Microbiome definition re-visited: Old concepts and new challenges. Microbiome, 8, 103. https://doi.org/10.1186/s40168-020-00875-0.10.1186/s40168-020-00875-0732952332605663
]Search in Google Scholar
[
Bergmann, K. R., Lie, S. X. L., Tian, R., Kushnir, A., Turner, J. R., Li, H.-L., Chou, P. M., Weber, C. R., Plaen, I. G. (2013). Bifidobacteria stabilize claudins at tight junctions and prevent intestinal barrier dysfunction in mouse necrotizing fnterocolitis. Amer. J. Pathol., 182 (5), 2013; https://dx.doi.org/10.1016/j.ajpath.2013.01.01310.1016/j.ajpath.2013.01.013364472523470164
]Search in Google Scholar
[
Binienda, A., Twardowska, A., Makaro, A., Salkaga, M. (2020). Dietary carbohydrates and lipids in the pathogenesis of leaky gut syndrome: An overview. Int. J. Mol. Sci., 21, 8368; DOI: 10.3390/ijms21218368.10.3390/ijms21218368766463833171587
]Search in Google Scholar
[
Bischoff, S. C., Barbara, G., Buurman, W., Ockhuizen, T., Schulzke, J. D., Serino, M., Tilg, H., Watson, A., Wells, J. M. (2014). Intestinal permeability — a new target for disease prevention and therapy. BMC Gastroenterology, 14, 189. http://www.biomedcentral.com/1471-230X/14/18910.1186/s12876-014-0189-7425399125407511
]Search in Google Scholar
[
Blackwood, B. P., Wood, D. R., Yuan, C. Y., Nicolas, J. D., Griffiths, A., Mestan, K., Hunter, C. J. (2015). Urinary claudin-2 measurements as a predictor of necrotizing enterocolitis: A pilot study. J. Neonatal Surg., 4 (4), 43.10.47338/jns.v4.457
]Search in Google Scholar
[
Campbell, J. A., Corrigall, A. V., Guy, A., Kirsch, R. E. (1991). Immunhistologic localisation of alpha, mu, and pi class gluthathione S-transferase in human tissues. Cancer (Phila), 61, 1608–1613.10.1002/1097-0142(19910315)67:6<1608::AID-CNCR2820670623>3.0.CO;2-S
]Search in Google Scholar
[
Cardoso-Silva, D., Delbue, D., Itzlinger, A., Moerkens, R., Withoff, S., Branchi, F., Schumann, M. (2019). Intestinal barrier function in gluten-related disorders. Nutrients, 11 (10), 2325. DOI: 10.3390/nu11102325.10.3390/nu11102325
]Search in Google Scholar
[
Chakaroun, R. M., Massier, L. Kovacs, P. (2020). Gut microbiome, intestinal permeability, and tissue bacteria in metabolic disease: Perpetrators or bystanders? Nutrients, 12, 1082; DOI:10.3390/nu1204108210.3390/nu12041082
]Search in Google Scholar
[
Clarke, L. L. (2009). A guide to Ussing chamber studies of mouse intestine. Amer. J. Physiol. Gastrointest. Liver Physiol., 296, G1151–G1166.10.1152/ajpgi.90649.2008
]Search in Google Scholar
[
Crenn, P., Coudray-Lucas, C., Thuillier, F., Cynober, L., Messing, B. (2000). Postabsorptive plasma citrulline concentration is a marker of absorptive enterocyte mass and intestinal failure in humans. Gastroenterology, 119, 1496–1505.10.1053/gast.2000.2022711113071
]Search in Google Scholar
[
Crenn, P., Vahedi, K., Lavergne-Slove, A., Cynober, L., Matuchansky, C., Messing, B. (2003). Plasma citrulline: A marker of enterocyte mass in villous atrophy-associated small bowel disease. Gastroenterology, 124, 1210–1219.10.1016/S0016-5085(03)00170-712730862
]Search in Google Scholar
[
Dastych, M., Dastych, M. Jr., Novotna, H., Cihalova, J. (2008). Lactulose/mannitol test and specificity, sensitivity, and area under curve of intestinal permeability parameters in patients with liver cirrhosis and Crohn’s disease. Dig. Dis. Sci., 53, 2789–2792. DOI: 10.1007/s10620-007-0184-8.10.1007/s10620-007-0184-818320320
]Search in Google Scholar
[
Davenport, E. R., Sanders, J. G., Song, S. J., Amato, K. R., Clark, A. G., Knight, R. (2017). The human microbiome in evolution. BMC Biology, 15, 127. DOI 10.1186/s12915-017-0454-7.10.1186/s12915-017-0454-7574439429282061
]Search in Google Scholar
[
DiTommaso, N., Gasbarrini, A., Ponziani, F. R. (2021). Intestinal barrier in human health and disease. Int. J. Environ. Res. Public Health, 18,12836. https://doi.org/10.3390/ijerph182312836.10.3390/ijerph182312836865720534886561
]Search in Google Scholar
[
Dominguez-Bello, M. G., Godoy-Vitorino, F., Knight, R., Blaser, M. J. (2019). Role of the microbiome in human development. Gut, 68, 1108–1114. DOI: 10.1136/gutjnl-2018-317503.10.1136/gutjnl-2018-317503658075530670574
]Search in Google Scholar
[
Farshchi, M. K., Azad, F. J., Salari, R., Mirsadraee, M., Anushiravani, M. (2017). A viewpoint on the leaky gut syndrome to treat allergic asthma: A novel opinion. J. Evidence-Based Complem. Altern. Med., 22 (3) 378–380.10.1177/2156587216682169587116630208732
]Search in Google Scholar
[
Fasano, A. (2020). All disease begins in the (leaky) gut: Role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases [version 1; peer review: 3 approved]. F1000Research, 9 (F1000 Faculty Rev), 69. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6996528/.
]Search in Google Scholar
[
Fasano, A. (2012a). Intestinal permeability and its regulation by zonulin: Diagnostic and therapeutic implications. Clin. Gastroenterol. Hepatol., 10 (10), 1096–1100. DOI: 10.1016/j.cgh.2012.08.012.10.1016/j.cgh.2012.08.012345851122902773
]Search in Google Scholar
[
Fasano, A. (2012b). Zonulin, regulation of tight junctions, and autoimmune diseases. Ann. N. Y. Acad. Sci., 1258 (1), 25–33. DOI: 10.1111/j.1749-6632.2012.06538.x.10.1111/j.1749-6632.2012.06538.x338470322731712
]Search in Google Scholar
[
Findley, M. K., Koval, M. (2009). Regulation and roles for claudin-family tight junction proteins. Life, 61 (4), 431–437. DOI: 10.1002/iub.175.10.1002/iub.175270811719319969
]Search in Google Scholar
[
Furuhashi, M., Hotamisligil, G. S. (2008). Fatty acid-binding proteins: Role in metabolic diseases and potential as drug targets. Nat. Rev. Drug Discov., 7 (6), 489. DOI: 10.1038/nrd2589.10.1038/nrd2589282102718511927
]Search in Google Scholar
[
Garcia-Hernandez, V., Quiros, M., Nusrat, A. (2017). Intestinal epithelial claudins: Expression and regulation in homeostasis and inflammation. Ann. N. Y. Acad. Sci., 2017 1397 (1), 66–79. DOI: 10.1111/nyas.13360.10.1111/nyas.13360554580128493289
]Search in Google Scholar
[
Gearhart, S. L., Delaney, C. P., Senagore, A. J., Banbury, M. KJ., Remzi, F. H., Kiran, R. P., Fazio, V. W. (2003). Prospective assessment of the predictive value of alpha-glutathione S-transferase for intestinal ischemia. Amer. Surg., 69, 324–329.10.1177/000313480306900409
]Search in Google Scholar
[
Gerova, V. A., Stoynov, S. G., Katsarov, D. S., Svinarov, D. A. (2011). Increased intestinal permeability in inflammatory bowel diseases assessed by iohexol test. World J. Gastroenterol., 17 (17), 2211–2215.10.3748/wjg.v17.i17.2211
]Search in Google Scholar
[
Gerova, V. A., Svinarov, D. A., Nakov, R. V., Stoynov, S. G., Tankova, L. T., Nakov, V. N. (2020). Intestinal barrier dysfunction in liver cirrhosis assessed by iohexol test. Eur. Rev. Med. Pharm. Sci., 24, 315–322.
]Search in Google Scholar
[
Grootjans, J., Thuijls, G., Verdam, F., Derikx, J. P., Lenaerts, K., Buurman, W. A. (2010). Non-invasive assessment of barrier integrity and function of the human gut. World J. Gastrointest. Surg., 2 (3), 61–69.10.4240/wjgs.v2.i3.61299922121160852
]Search in Google Scholar
[
Griffiths, V., Al Assaf, N., Khan, R. (2021). Review of claudin proteins as potential biomarkers for necrotizing enterocolitis. Irish J. Med. Sci., 190 (4),1465–1472. https://doi.org/10.1007/s11845-020-02490-2.10.1007/s11845-020-02490-2852151433492576
]Search in Google Scholar
[
Halme, L., Turunen, U., Tuominen, J., Forsström, T., Turpeinen, U. (2000). Comparison of iohexol and lactulose-mannitol tests as markers of disease activity in patients with inflammatory bowel disease. Scand. J. Clin. Lab. Invest., 60, 695–702.10.1080/0036551005021642011218152
]Search in Google Scholar
[
Hansson, G. C. (2020). Mucins and the microbiome. Annu. Rev. Biochem., 89, 769–793. DOI:10.1146/annurev-biochem-011520-105053.10.1146/annurev-biochem-011520-105053844234132243763
]Search in Google Scholar
[
Herrmann, J. R., Turner, J. R. (2016). Beyond Ussing’s chambers: Contemporary thoughts on integration of transepithelial transport. Amer. J. Physiol. Cell Physiol., 310, C423–C431. DOI: 10.1152/ajpcell.00348.2015.10.1152/ajpcell.00348.2015479628626702131
]Search in Google Scholar
[
Hollander, D., Kaunitz, J. D. (2020). The “Leaky gut”: Tight junctions but loose associations? Dig. Dis. Sci., 65 (5), 1277–1287. DOI: 10.1007/s10620-019-05777-2.10.1007/s10620-019-05777-2719372331471860
]Search in Google Scholar
[
Horton, F., Wright, J., Smith, L., Hinton, P. J., Robertson, M. D. (2014). Increased intestinal permeability to oral chromium (51Cr) -EDTA in human Type 2 diabetes. Diabet. Med., 31, 559–563.10.1111/dme.1236024236770
]Search in Google Scholar
[
Human Microbiome Project. https://hmpdacc.org/ihmp/overview/ (accessed 20.02.2022).
]Search in Google Scholar
[
Jaworska, K., Konop, M., Bielinska, K., Hutsch, T., Dziekiewicz, M., Banaszkiewicz, A., Ufnal, M. (2019). Inflammatory bowel disease is associated with increased gut-to-blood penetration of short-chain fatty acids: A new, non-invasive marker of a functional intestinal lesion. Exper. Physiol.,104, 1226–1236.10.1113/EP08777331243807
]Search in Google Scholar
[
Johansson, M. E. V., Hansson, G. C. (2016). Immunological aspects of intestinal mucus and mucins. Nat. Rev. Immunol., 16, 639–649. DOI: 10.1038/nri.2016.88.10.1038/nri.2016.88643529727498766
]Search in Google Scholar
[
Kessoku, T., Kobayashi, T., Tanaka, K., Yamamoto, A., Takahashi, K., Iwaki, M., Ozaki, A., Kasai, Y., Nogami, A., Honda, Y., et al. (2021). The role of leaky gut in nonalcoholic fatty liver disease: A novel therapeutic target. Int. J. Mol. Sci., 22, 8161. https://doi.org/10.3390/ijms22158161.10.3390/ijms22158161834747834360923
]Search in Google Scholar
[
Khoshbin, K., Khanna, L., Maselli, D., Atieh, J., Breen-Lyles, M., Arndt, K., Rhoten, D., Dyer, R. B., Singh, R. J., Nayar, S., et al. (2021). Development and validation of test for “leaky gut” small intestinal and colonic permeability using sugars in healthy adults. Gastroenterology, 161 (2), 463–475.e13. DOI: 10.1053/j.gastro.2021.04.020.10.1053/j.gastro.2021.04.020832888533865841
]Search in Google Scholar
[
Khurana, S., Corbally, M. T., Manning, F., Armenise, T., Kierce, B., Kilty, C. (2002). Glutathione S-transferase: A potential new marker of intestinal ischemia. J. Pediatr. Surg., 37 (11), 1543–1548.10.1053/jpsu.2002.3618112407536
]Search in Google Scholar
[
Kinashi, Y., Hase, K (2021). Partners in leaky gut syndrome: Intestinal dysbiosis and autoimmunity. Front. Immunol., 12, 673708. DOI: 10.3389/fimmu.2021.673708.10.3389/fimmu.2021.673708810030633968085
]Search in Google Scholar
[
Knezevic, J., Starchl, C., Berisha, A. T., Amrein, K. (2020). Thyroid-gut-axis: How does the microbiota influence thyroid function? Nutrient, 12, 1769. DOI: 10.3390/nu12061769.10.3390/nu12061769735320332545596
]Search in Google Scholar
[
Krug, S. M., Schulzke, J. D., Fromm, M. (2014). Tight junction, selective permeability, and related diseases. Semin. Cell Dev. Biol., 36, 166–176.10.1016/j.semcdb.2014.09.00225220018
]Search in Google Scholar
[
Larsen, R., Mertz-Nielsen, A., Hansen, M. B., Poulsen S. S., Bindslev, N. (2001). Novel modified Ussing chamber for the study of absorption and secretion in human endoscopic biopsies. Acta Physiol. Scand., 173 (2), 213–222.10.1046/j.1365-201X.2001.00865.x11683679
]Search in Google Scholar
[
Loret, S., Nollevaux, G., Remacle, R., Klimek, M., Barakat, I., Deloyer, P., Grandfilks, C., Dandrifosse, G. (2004). Analysis of PEG 400 and 4000 in urine for gut permeability assessment using solid phase extraction and gel permeation chromatography with refractometric detection. J. Chromatogr., 805 (2), 195–202.10.1016/j.jchromb.2004.02.03315135090
]Search in Google Scholar
[
Lutgens, L. C., Blijlevens, N. M., Deutz, N. E., Donnely, J. P., Lambin, P., de Pauw, B. E. (2005). Monitoring myeloablative therapy-induced small bowel toxicity by serum citrulline concentration: A comparison with sugar permeability tests. Cancer, 103,191–199.10.1002/cncr.2073315573372
]Search in Google Scholar
[
March, D. S. (2017). Intestinal fatty acid-binding protein and gut permeability responses to exercise. Eur. J. Appl. Physiol., 117, 931–941. DOI: 10.1007/s00421-017-3582-4.10.1007/s00421-017-3582-4538872028290057
]Search in Google Scholar
[
Marchesi, J. R., Ravel, J. (2015). The vocabulary of microbiome research: A proposal. Microbiome, 3, 31.10.1186/s40168-015-0094-5452006126229597
]Search in Google Scholar
[
Michielan, A., D’Incà, R. (2015). Intestinal permeability in inflammatory bowel disease: Pathogenesis, clinical evaluation, and therapy of leaky gut. Hindawi Publ. Corp. Med. Inflamm., 2015, 628157. http://dx.doi.org/10.1155/2015/628157.10.1155/2015/628157463710426582965
]Search in Google Scholar
[
Mohajeri, M. H., Brummer, R. J., Rastall, R. A., Weersma, R. K., Harmsen, H. J. M., Faas, M., Eggersdorfer, M. (2018). The role of the microbiome for human health: From basic science to clinical applications. Eur. J. Nut., 57 (Suppl 1), S1–S14. https://doi.org/10.1007/00394-018-1703-4.
]Search in Google Scholar
[
Oami, T., Coopersmith, C. M. (2021). Measurement of intestinal permeability during sepsis. Methods Mol. Biol., 2321, 169–175. DOI: 10.1007/978-1-0716-1488-4_15.10.1007/978-1-0716-1488-4_15830174334048016
]Search in Google Scholar
[
Obrenovich, M. E. M. (2018). Leaky gut, leaky brain? Microorganisms, 6, 107. DOI: 10.3390/microorganisms6040107.10.3390/microorganisms6040107631344530340384
]Search in Google Scholar
[
Paone, P., Cani, P. D. (2020). Mucus barrier, mucins and gut microbiota: The expected slimy partners? Gut, 69, 2232–2243. DOI: 10.1136/gutjnl-2020-322260.10.1136/gutjnl-2020-322260767748732917747
]Search in Google Scholar
[
Paray, B. A., Albeshr, M. F., Jan, A. T., Rather, I. A. (2020). Leaky gut and autoimmunity: An intricate balance in individuals health and the diseased state. Int. J. Mol. Sci., 21, 9770. DOI: 10.3390/ijms21249770.10.3390/ijms21249770776745333371435
]Search in Google Scholar
[
Pelaseyed, T., Hansson, G. C. (2020). Membrane mucins of the intestine at a glance. J. Cell Sci., 133, jcs240929. DOI: 10.1242/jcs.240929.10.1242/jcs.240929707504832169835
]Search in Google Scholar
[
Peled, Y., Watz, C., Gilat, T. (1985). Measurement of intestinal permeability using 51Cr-EDTA. Amer. J. Gastroenterol., 80, 770–773.
]Search in Google Scholar
[
Pietrzak, B., Tomela, K., Olejnik-Schmidt, A., Mackiewicz, A., Schmidt, M. (2020). Secretory IgA in intestinal mucosal secretions as an adaptive barrier against microbial cells. Int. J. Mol. Sci., 21, 9254. DOI: 10.3390/ijms21239254.10.3390/ijms21239254773143133291586
]Search in Google Scholar
[
Portincasa, P., Bonfrate, L., Khalil, M., de Angelis, M., Calabrese, F. M., D’Amato, M., Wang, D. Q. H., Di Ciaula, A. (2022). Intestinal barrier and permeability in health, obesity and NAFLD. Biomedicines, 10, 83. https://doi.org/10.3390/biomedicines10010083.10.3390/biomedicines10010083877301035052763
]Search in Google Scholar
[
Schoultz, I., Keita, A. V. (2020). The intestinal barrier and current techniques for the assessment of gut permeability. Cells, 9, 1909. DOI: 10.3390/cells9081909.10.3390/cells9081909746371732824536
]Search in Google Scholar
[
Schurink, M., Kooi, E. M. W., Hulzebos, C. V., Kox, R. G., Groen, H., Heineman, E., Bos, A. F., Hulscher, J. B. F. (2015). Intestinal fatty acid-binding protein as a diagnostic marker for complicated and uncomplicated necrotizing enterocolitis: A prospective cohort study. PLoS ONE, 10 (3), e0121336. DOI: 10.1371/journal.pone.0121336.10.1371/journal.pone.0121336436810025793701
]Search in Google Scholar
[
Sequeira, I. R., Lentle, R. G., Kruger, M. C., Hurst, R. D. (2014). Standardising the lactulose mannitol test of gut permeability to minimise error and promote comparability. PLoS ONE, 9 (6), e99256. DOI: 10.1371/journal.pone.0099256.10.1371/journal.pone.0099256404711024901524
]Search in Google Scholar
[
Shulman, R. J., Jarett, M. EW., Cain, K. C., Broussard, E. K., Heitkemper, M. M. (2014). Associations among gut permeability, inflammatory markers and symptoms in patients with irritable bowel syndrome. J. Gastroenterol., 49 (11), 1467–1476. DOI: 10.1007/s00535-013-0919-6.10.1007/s00535-013-0919-6410267424435814
]Search in Google Scholar
[
Sicard, J.-F., Le Bihan, G., Vogeleer, P., Jacques, M., Harel, J. (2017). Interactions of intestinal bacteria with components of the intestinal mucus. Front. Cell. Infect. Microbiol., 7, 387. DOI: 10.3389/fcimb.2017.00387.10.3389/fcimb.2017.00387559195228929087
]Search in Google Scholar
[
Smith, P. L. (1996). Methods for evaluating intestinal permeability and metabolism in vitro. Pharm. Biotechnol., 8, 13–34.10.1007/978-1-4899-1863-5_28791802
]Search in Google Scholar
[
Sturgeon, C., Fasano, A. (2016). Zonulin, a regulator of epithelial and endothelial barrier functions, and its involvement in chronic inflammatory diseases. Tissue Barriers, 4 (4), e1251384. http://dx.doi.org/10.1080/21688370.2016.125138410.1080/21688370.2016.1251384521434728123927
]Search in Google Scholar
[
Sugimoto, M. (1995). Glutathione S-transferases (GSTs). Nihon Rinsho, 53 (5), 1253–1259. 7602788.
]Search in Google Scholar
[
Suzuki, T. (2020). Regulation of the intestinal barrier by nutrients: The role of tight junctions. Anim. Sci. J., 91, e13357. https://doi.org/10.1111/asj.13357.10.1111/asj.13357718724032219956
]Search in Google Scholar
[
Takiishi, T., Fenero, C. I. M., Câmara, N. O. S. (2017). Intestinal barrier and gut microbiota: Shaping our immune responses throughout life. Tissue Barriers, 5 (4), e1373208. https://doi.org/10.1080/21688370.2017.1373208.10.1080/21688370.2017.1373208578842528956703
]Search in Google Scholar
[
Thomson, A., Smart, K., Somerville, M. S., Lauder, S. N., Appanna, G., Horwood, J., Raj, L. S., Sristava, B., Durai, D., Scurr, M. J., et al. (2019). The Ussing chamber system for measuring intestinal permeability in health and disease. BMC Gastroenterol., 19, 98.10.1186/s12876-019-1002-4658511131221083
]Search in Google Scholar
[
Thuijls, G., Derikx, J. P., de Haan, J. J., Grootajans, J., de Bruïne, A., Masclee, A. A. M., Heineman, E., Buurman, W. A. (2009). Urine-based detection of intestinal tight junction loss. J. Clin. Gastroenterol., 44 (1), e14–e19. DOI: 10.1097/MCG.0b013e31819f5652.10.1097/MCG.0b013e31819f565219525861
]Search in Google Scholar
[
Turpin, W., Lee, S. H., Raygoza Garay, J. A., Madsen, K. L., Meddings, J. B., Bedrani, L., Power, N., Espin-Garcia, O., Xu, W., Smith, M. I., et al. (2020). Increased intestinal permeability is associated with later development of Crohn’s disease. Gastroenterology, 159, 2092–2100.e2095.10.1053/j.gastro.2020.08.00532791132
]Search in Google Scholar
[
Vancamelbeke, M., Vermeire, S. (2017). The intestinal barrier: A fundamental role in health and disease. Expert Rev. Gastroenterol. Hepatol., 11 (9), 821–834. DOI: 10.1080/17474124.2017.1343143.10.1080/17474124.2017.1343143610480428650209
]Search in Google Scholar
[
Vuong, C. N., Mukllenix, G. J., Kidd, M. T., Bottje, W. G., Hargis, B. M., Tellez-Isaias, G. (2021). Research note: Modified serum fluorescein isothiocyanate dextran (FITC-d) assay procedure to determine intestinal permeability in poultry fed diets high in natural or synthetic pigments. Poultry Sci., 100, 101138.10.1016/j.psj.2021.101138813173733975047
]Search in Google Scholar
[
Watson, C. J., Rowland, M., Warhurst, G. (2001). Functional modeling of tight junctions in intestinal cell monolayers using polyethylene glycol oligomers. Amer. J. Physiol. Cell Physiol., 281, C388–C397.10.1152/ajpcell.2001.281.2.C38811443038
]Search in Google Scholar
[
Woting, A., Blaut, M. (2018). Small intestinal permeability and gut-transit time determined with low and high molecular weight fluorescein isothiocyanate-dextrans in C3H mice. Nutrients, 10, 685. DOI: 10.3390w/nu10060685.
]Search in Google Scholar
[
Wuyts, B., Riwthorst, D., Brouwers, J., Tack, J., Annaert, P., Augustijns, P. (2015). Evaluation of fasted and fed state simulated and human intestinal fluids as solvent system in the Ussing chambers model to explore food effects on intestinal permeability. Int. J. Pharmaceut., 478, 736–744.10.1016/j.ijpharm.2014.12.02125510602
]Search in Google Scholar
[
Zheng, D. Liao, H., Chen, S., Liu, X., Mao, C., Zhang, C., Meng, M., Wang, Zhi, Wang, Y., Jianget, Q., et al. (2021). Elevated levels of circulating biomarkers related to leaky gut syndrome and bacterial translocation are associated with Graves’ disease. Front. Endocrinol., 12, 796212. DOI: 10.3389/fendo.2021.796212.10.3389/fendo.2021.796212871683134975767
]Search in Google Scholar